Literature DB >> 19424590

Reorganization of the integrin alpha2 subunit controls cell adhesion and cancer cell invasion in prostate cancer.

Severine Van Slambrouck1, Aaron R Jenkins, Anntherese E Romero, Wim F A Steelant.   

Abstract

The mechanisms of invasion and metastasis are poorly understood. Our previous studies demonstrated that cancer cell invasion may result from reorganization of membrane molecules, thereby initiating signaling pathways. To increase our understanding on how cancer cells govern metastases we studied the established LNCaP prostate cancer progression model. Herein we show that the bone metastatic derivative cell line, C4-2B, displays changes in adhesion to collagen type I and invasion into collagen type I. Moreover, we found that these changes were concomitant with activation of the FAK/src/paxillin/Rac/JNK signaling pathway and increased activity of matrix metalloproteinases (MMPs)-2 and -9. Inhibition of src and JNK resulted in inhibition of adhesion and invasion, and deactivation of the signaling molecules in the identified pathway as well as reduced activity of MMPs. Additionally, we found a pivotal role for the integrin alpha2 subunit since lateral redistribution and clustering were responsible for activation of the downstream signaling and function blocking of the integrin alpha2 subunit resulted in poor adhesion and inhibition of invasion. In conclusion, our results suggest that invasion of prostate cancer cells can be ascribed to reorganization and clustering of integrin alpha2 subunits, resulting in activation of associated FAK/src/paxillin/Rac/JNK, leading to increased activity of MMPs and thus invasion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19424590      PMCID: PMC3235691          DOI: 10.3892/ijo_00000302

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  44 in total

Review 1.  Integrin signaling revisited.

Authors:  M A Schwartz
Journal:  Trends Cell Biol       Date:  2001-12       Impact factor: 20.808

2.  Homophilic interactions of Tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways.

Authors:  In-Kee Hong; Young-June Jin; Hee-Jung Byun; Doo-Il Jeoung; Young-Myeong Kim; Hansoo Lee
Journal:  J Biol Chem       Date:  2006-06-23       Impact factor: 5.157

Review 3.  Integrin-regulated FAK-Src signaling in normal and cancer cells.

Authors:  Satyajit K Mitra; David D Schlaepfer
Journal:  Curr Opin Cell Biol       Date:  2006-08-17       Impact factor: 8.382

Review 4.  Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain.

Authors:  S I Hakomori
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

5.  Clustering of monosialyl-Gb5 initiates downstream signalling events leading to invasion of MCF-7 breast cancer cells.

Authors:  Severine Van Slambrouck; Wim F A Steelant
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

6.  Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion.

Authors:  Shu-Yi Chen; Hong-Chen Chen
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 7.  Gelatinase-mediated migration and invasion of cancer cells.

Authors:  Mikael Björklund; Erkki Koivunen
Journal:  Biochim Biophys Acta       Date:  2005-04-12

8.  LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.

Authors:  G N Thalmann; R A Sikes; T T Wu; A Degeorges; S M Chang; M Ozen; S Pathak; L W Chung
Journal:  Prostate       Date:  2000-07-01       Impact factor: 4.104

Review 9.  Clinical significance of FAK expression in human neoplasia.

Authors:  Nikolaos A Chatzizacharias; Gregory P Kouraklis; Stamatios E Theocharis
Journal:  Histol Histopathol       Date:  2008-05       Impact factor: 2.303

10.  Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells.

Authors:  Sophia C Sigstedt; Carla J Hooten; Manika C Callewaert; Aaron R Jenkins; Anntherese E Romero; Michael J Pullin; Alexander Kornienko; Timothy K Lowrey; Severine Van Slambrouck; Wim F A Steelant
Journal:  Int J Oncol       Date:  2008-05       Impact factor: 5.650

View more
  29 in total

1.  SKI-606, an Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancer.

Authors:  Won Gu Kim; Celine J Guigon; Laura Fozzatti; Jeong Won Park; Changxue Lu; Mark C Willingham; Sheue-yann Cheng
Journal:  Clin Cancer Res       Date:  2012-01-23       Impact factor: 12.531

2.  A 3D matrix platform for the rapid generation of therapeutic anti-human carcinoma monoclonal antibodies.

Authors:  David T Dudley; Xiao-Yan Li; Casey Y Hu; Celina G Kleer; Amanda L Willis; Stephen J Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

3.  Inhibitory effects of ethacrynic acid analogues lacking the α,β-unsaturated carbonyl unit and para-acylated phenols on human cancer cells.

Authors:  Zack E Bryant; Romy F J Janser; Medina Jabarkhail; Melissa S Candelaria-Lyons; Brittni B Romero; Severine Van slambrouck; Wim F A Steelant; Ingo Janser
Journal:  Bioorg Med Chem Lett       Date:  2010-12-19       Impact factor: 2.823

4.  Abnormal cell properties and down-regulated FAK-Src complex signaling in B lymphoblasts of autistic subjects.

Authors:  Hongen Wei; Mazhar Malik; Ashfaq M Sheikh; George Merz; W Ted Brown; Xiaohong Li
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

5.  Structure and Function of a Prostate Cancer Dissemination-Permissive Extracellular Matrix.

Authors:  Marie-France Penet; Samata Kakkad; Arvind P Pathak; Balaji Krishnamachary; Yelena Mironchik; Venu Raman; Meiyappan Solaiyappan; Zaver M Bhujwalla
Journal:  Clin Cancer Res       Date:  2016-10-31       Impact factor: 12.531

6.  Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells.

Authors:  R Minelli; L Serpe; P Pettazzoni; V Minero; G Barrera; Cl Gigliotti; R Mesturini; A C Rosa; P Gasco; N Vivenza; E Muntoni; R Fantozzi; U Dianzani; G P Zara; C Dianzani
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

7.  Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells.

Authors:  Steffen Wedel; Lukasz Hudak; Jens-Michael Seibel; Jasmina Makarević; Eva Juengel; Igor Tsaur; Christoph Wiesner; Axel Haferkamp; Roman A Blaheta
Journal:  Clin Exp Metastasis       Date:  2011-03-31       Impact factor: 5.150

8.  Integrin alpha2beta 1 (α2β1) promotes prostate cancer skeletal metastasis.

Authors:  Joseph L Sottnik; Stephanie Daignault-Newton; Xiaotun Zhang; Colm Morrissey; Maha H Hussain; Evan T Keller; Christopher L Hall
Journal:  Clin Exp Metastasis       Date:  2012-12-15       Impact factor: 5.150

9.  AsialoGM1 and integrin alpha2beta1 mediate prostate cancer progression.

Authors:  Severine Van Slambrouck; John Hilkens; Marco Bisoffi; Wim F A Steelant
Journal:  Int J Oncol       Date:  2009-10       Impact factor: 5.650

10.  LGALS3BP, lectin galactoside-binding soluble 3 binding protein, promotes oncogenic cellular events impeded by antibody intervention.

Authors:  P Stampolidis; A Ullrich; S Iacobelli
Journal:  Oncogene       Date:  2013-12-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.